What is the Role of Measuring Urinary Gluten Immunogenic Peptides in Clinical Practice in Patients with Coeliac Disease?
The urinary gluten immunogenic peptide does not have a role in identifying villous atrophy. Therefore, to assess for villous atrophy an upper gastrointestinal endoscopy is still required.
Authors
- Nicoletta Nandi (ORCID: https://orcid.org/0000-0002-4450-2593)
- Suneil A Raju (ORCID: https://orcid.org/0000-0001-5528-917X)
- Marios Hadjivassiliou (ORCID: https://orcid.org/0000-0003-2542-8954)
- Calvin M. Johnson (ORCID: https://orcid.org/0000-0001-5213-5917)
- Mohamed G. Shiha (ORCID: https://orcid.org/0000-0002-2713-8355)
- Nick Trott (ORCID: https://orcid.org/0000-0001-8872-8773)
- Hugo A. Penny (ORCID: https://orcid.org/0000-0003-1610-2282)
- Olivia Green (ORCID: https://orcid.org/0009-0003-6819-5780)
- David S. Sanders
- Graeme Wild
- K.C. Ingham
Institutions
- National Health Service (GB)
- Royal Hallamshire Hospital (GB)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- Sheffield Health and Social Care NHS Foundation Trust (GB)
- University of Sheffield (GB)
Publication Details
- Journal
- Journal of Gastrointestinal and Liver Diseases
- Published
- 2024-12-28
- DOI
- https://doi.org/10.15403/jgld-5659
- Citations
- 2
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.93